Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Cappello (Palermo, Italy). Chaperonins in COPD. Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD

Member's Comments

No comment yet.

Related content which might interest you: COPD Source: ERS Course 2019 - Summer school of adult respiratory medicine Year: 2019 COPD Source: Eur Respir Monogr 2017; 77: 13-24 Year: 2017 COPD Source: ERS Skills Course 2016 Year: 2016 COPD Source: ERS Course 2018 - Summer school of adult respiratory medicine Year: 2018 The COPD CO-factor Source: Eur Respir J 2007; 30: 1032-1034 Year: 2007 COPD Source: ERS Lung Science Conference 2016 Year: 2016 COVID-19 and COPD Source: Eur Respir J, 56 (2) 2002108; 10.1183/13993003.02108-2020 Year: 2020 COPD Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017 COPD Source: Eur Respir Monogr 2017; 77: 147-166 Year: 2017 COPD Source: Annual Congress 2010 - Clinical reviews of the ERS's 20th Anniversary Year: COPD, smoking cessation, tuberculosis and noninvasive ventilation Year: 2010 Exacerbations of COPD Source: Eur Respir Rev, 27 (147) 170103; 10.1183/16000617.0103-2017 Year: 2018 Exacerbations of asthma and COPD Source: ERS Skills Course 2016 Year: 2016 Exacerbations of asthma and COPD Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017 Exacerbations of asthma and COPD Source: ERS Course 2018 - Summer school of adult respiratory medicine Year: 2018 Sphingolipids in COPD Source: Eur Respir Rev, 28 (154) 190047; 10.1183/16000617.0047-2019 Year: 2019 Airway glucose in COPD exacerbations Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients Year: 2016